John David Finley, Chief Financial Officer at PALISADE BIO, INC. (PALI), bought 7,500 shares at $1.09 ($8K) on 2022-03-24, disclosed to the SEC on 2022-03-25.
Open-market purchase of $8k PALI by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| PALI | BUY | 2024-05-28 | $5K | — | Filing → |
| PALI | BUY | 2024-02-07 | $5K | — | Filing → |
| PALI | BUY | 2024-02-01 | $6K | — | Filing → |